There is a great deal of detail in the Proposed Rule as to what characteristics make up a Covered Outpatient Drug and explains that if the drug does not fall into one of these slots a manufacturer can submit detail to show it should be a COD. What type of data is CMS requiring, where should that data be submitted, and who will make that determination? Will CMS be making a business decision on these submissions or will there be pharmaceutical professionals deciding the products to which patients should have access?
CA--Professional Provider Services
This is comment on Proposed Rule
Medicaid Program: Covered Outpatient Drugs
View Comment
Related Comments
View AllPublic Submission Posted: 03/02/2012 ID: CMS-2012-0012-0004
Apr 02,2012 11:59 PM ET
Public Submission Posted: 03/14/2012 ID: CMS-2012-0012-0007
Apr 02,2012 11:59 PM ET
Public Submission Posted: 03/28/2012 ID: CMS-2012-0012-0008
Apr 02,2012 11:59 PM ET
Public Submission Posted: 03/28/2012 ID: CMS-2012-0012-0009
Apr 02,2012 11:59 PM ET
Public Submission Posted: 03/28/2012 ID: CMS-2012-0012-0010
Apr 02,2012 11:59 PM ET